Rumsfeld va profiter des vaccins contre la grippe aviaire

Rumsfeld va profiter des vaccins contre la grippe aviaire


- Who Owns the Rights on Tamiflu: Rumsfeld To Profit From Bird Flu Hoax
by Dr. Joseph Mercola October 26, 2005

Tout comme Cheney qui recoit de l'argent d'Halliburton qui raflent des contrats hypers juteux du gourvernements sans appels d'offres, Bush qui profite du petrole, Rumsfeld est aussi en conflit d'interets flagrant avec une compagnie qui s'apprete a faire fortune a cause du gouvernement et du vaccin Tamiflu.

Voila que soudainement il y a crise avec la grippe aviaire, et le gouvernement americain ( et probablement canadien aussi, a verifier...) declare qu'il doit acheter tout plein de vaccins (qui contiennent du mercure comme composant et qui n'a aucune utilite ou presque a part de nous intoxiquer) au prix de 2 milliards de dollards. La compagnie qui va rafler le gros lot est une compagnie qui a deja employe Rumsfeld et qui lui verse toujours des dividendes!!!!

C'est pas beau ca!


We bring to the attention of Global Research readers this important commentary by Dr.Joseph Mercola. The fundamnetal issue is who owns the intellectual property rights overTamiflu. The media reports suggest that the Swiss pharmaceutical company Roche will make billions. While the drug is produced by Roche, it was developed by Gilead Sciences Inc.which owns the intellectual property rights. Gilead, which has maintained a low profile, has outsourced the production to Roche. Donald Rumsfeld was appointed Chairman of Gilead Sciences, Inc. in 1997, a position which he held in the years prior to becoming Secretary of Defense in the Bush administration. Rumsfeld had been on the Board of Director from the establishment of Gilead in 1987.

Finally, the pieces of the puzzle start to add up. Not long ago, President Bush sought to instill panic in this country by telling us a minimum of 200,000 people will die from the avian flu pandemic, but it could be as bad as 2 million deaths in this country alone.
This hoax is then used to justify the immediate purchase of 80 million doses of Tamiflu, a worthless drug that in no way shape or form treats the avian flu, but only decreases the amount of days one is sick and can actually contribute to the virus having more lethal mutations.
So the U.S. placed an order for 20 million doses of this worthless drug at a price of $100 per dose. That comes to a staggering $2 billion.
We are being told that Roche manufactures Tamiflu and, in a recent New York Times article, they were battling whether or not they would allow generic drug companies to help increase their production.
But if you dig further you will find that a drug was actually developed by a company called Gilead that 10 years ago gave Roche the exclusive rights to market and sell Tamiflu.
Ahh, The Plot Thickens...
If you read the link below from Gilead, you'll discover Defense Secretary Donald Rumsfeld was made the chairman of Gilead in 1997.

Since Rumsfeld holds major portions of stock in Gilead, he will handsomely profit from the scare tactics of the government that is being used to justify the purchase of $2 billion of Tamiflu.

- Plague-infected mice escape from Jersey lab

Oups!!!!